AnalysisNews

VIVS today

$0.13-$0.01 (-7.83%)close Nov 13, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bearish

1 hourSymmetric Triangle

15 minBullish

5 minStrong Bearish

Daily trend turns up above $1.57

Key levels

Resistance$0.18

Resistance$0.15

Latest news & SEC filings

EarningsVivoSim Labs narrows quarterly loss as revenue rises

NewsVivoSim Labs to share multiparametric results at ACT 47th Annual Meeting

All VIVS news →

About VivoSim Labs

VivoSim Labs provides drug safety testing services to pharmaceutical and biotech companies, using lab-grown three-dimensional human liver and intestine tissues to assess toxicity. Its customers include drug developers at various stages of research. The company also runs its own early-stage drug discovery work and owns patents covering 3D bioprinting methods and engineered tissues. It operates in the United States.

Based on the company's 10-K filed Jul 14, 2026.

Nasdaq · Healthcare

VivoSim Labs, INC. (VIVS)

$0.13-0.01 (-7.83%)
WATCHLISTGrade: C+Risk: HIGH
1D5D1M1Y5YMaxSign up for all timeframes
0.140.160.170.190.13Oct 13Oct 21Oct 29Nov 6
High0.14
Low0.13
Open0.14
Volume374K
Avg Vol885K
VWAP0.13
30d High0.21
30d Low0.13
30d Chg-38.42%

What Is the Price Target for VIVS?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.14Upside: +0.0%Confidence: 20%Method: No Coverage

Is VIVS a Buy or Sell Right Now?

49
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing -9.0% YoY with ACCELERATING trend — accelerating momentum.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VIVS.

Start Free Trial →

Is VIVS Overvalued or Undervalued?

Valuation Verdict

N/A

Methods Used

N/A

Fair Value

$N/A

22

Moat Score

NONE

2/9

Piotroski Score

-71.9

Altman Z-Score

What Is Smart Money Doing with VIVS?

Insider Signal

NEUTRAL

1 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
Lialin Tony SergeofficerBuy10,000$3KAug 31, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

VIVS Growth Story

Revenue YoY

-9.0%

3yr Revenue CAGR

-29.3%

EPS Growth YoY

-214.71%

FCF Growth YoY

-14.3%

Revenue Trend

ACCELERATING

Dark Pool Trades for VIVS

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for VIVS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
24:24:10$0.132,200$$281BUY
23:14:07$0.134,484$$565BUY
22:30:33$0.121,871$$232SELL
22:28:04$0.131,000$$125SELL
21:41:05$0.133,000$$375SELL

5 dark pool trades shown · $$2K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for VivoSim Labs, INC. (VIVS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

VIVS — frequently asked questions

What is VIVS stock price today?

VivoSim Labs, INC. (VIVS) is at $0.13, down 7.83% (-$0.01) at the Nov 13, 2026 close.

Why is VIVS stock moving today?

Latest VIVS news — Nov 12, 2026: VivoSim Labs narrows quarterly loss as revenue rises · Nov 10, 2026: VivoSim Labs to share multiparametric results at ACT 47th Annual Meeting

Did VIVS beat earnings?

VIVS last reported on Aug 12, 2026: EPS -$0.25.

Does VIVS pay a dividend?

VIVS does not currently pay a dividend.

What are VIVS support and resistance levels?

Resistance: $0.15, $0.18, $0.26.

What are insiders doing with VIVS?

Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.

What is the latest news on VIVS?

Nov 12, 2026: VivoSim Labs narrows quarterly loss as revenue rises · Nov 10, 2026: VivoSim Labs to share multiparametric results at ACT 47th Annual Meeting